See the latest news and media coverage for EXBIO. We track all announcements, press releases, and industry mentions in real time, all in one place.
Flow cytometry reagent and diagnostic product manufacturer
exbio.czLast updated
In short: EXBIO expanded its flow cytometry portfolio with new PNH testing kits and antibodies while achieving key IVDR compliance milestones.
The ready-to-use flow cytometry reagent simplifies laboratory workflow and enables accurate detection of complement-mediated opsonization on red blood cells for Paroxysmal Nocturnal Hemoglobinuria diagnosis.
Launched in 2023, the CE-IVD kit sells in 45 countries; RUO version serves 7 more, including the US. Built on consensus guidelines for high-sensitivity PNH diagnostics.
Multicenter study uses EXBIO's dry antibody tubes for standardized MRD detection in pediatric T-ALL, achieving high concordance and stability.
IVD medical devices for flow cytometry meet IVDR requirements. EU Declaration of Conformity signed on 01.07.2024 and 09.12.2024. New compliant batches launch in Q4/2024 and Q1/2025.
Track EXBIO and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to EXBIO and other trending companies.